ANSAID Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Ansaid, and what generic alternatives are available?

Ansaid is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in ANSAID is flurbiprofen. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the flurbiprofen profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ansaid

A generic version of ANSAID was approved as flurbiprofen by TEVA on May 31^st, 1995.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ANSAID?
What are the global sales for ANSAID?
What is Average Wholesale Price for ANSAID?

Summary for ANSAID

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	168
Clinical Trials:	3
Patent Applications:	1,800
Formulation / Manufacturing:	see details
DailyMed Link:	ANSAID at DailyMed

Drug patent expirations by year for ANSAID

Recent Clinical Trials for ANSAID

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Pfizer	Phase 1
United States Army Research Institute of Environmental Medicine	Phase 1
National Institute of Dental and Craniofacial Research (NIDCR)	Phase 2

See all ANSAID clinical trials

US Patents and Regulatory Information for ANSAID

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-002	Oct 31, 1988		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-003	Oct 31, 1988		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ANSAID

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-002	Oct 31, 1988	⤷ Sign Up	⤷ Sign Up
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-003	Oct 31, 1988	⤷ Sign Up	⤷ Sign Up
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-003	Oct 31, 1988	⤷ Sign Up	⤷ Sign Up
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-002	Oct 31, 1988	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ANSAID

See the table below for patents covering ANSAID around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Switzerland	454822	Procédé de préparation d'acides carboxyliques thérapeutiquement actifs	⤷ Sign Up
Finland	42712		⤷ Sign Up
Netherlands	152540		⤷ Sign Up
Czechoslovakia	163157		⤷ Sign Up
Netherlands	6500865		⤷ Sign Up
Germany	1518528		⤷ Sign Up
Belgium	658723		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ANSAID

Recent Clinical Trials for ANSAID

Make Better Decisions: Try a trial or see plans & pricing